Idenix Pharmaceuticals Inc. (IDIX)
Healthcare: Biotechnology
Schedule 13D and 13G filings submitted since 09/30/2011
| Filing Company | Date of Filing |
Total Reported Shares Owned |
Shares Reported on 13F |
|
|---|---|---|---|---|
| SC 13D | SOMMADOSSI JEAN-PIERRE | 02/10/2011 | 4,504,682 | 0 |
| SC 13D/A | NOVARTIS AG | 04/20/2011 | 33,185,191 | 0 |
| SC 13G/A | COLUMBIA WANGER ASSET MANAGEMENT LLC | 09/08/2011 | 0 | 0 |
| SC 13G/A | BROOKSIDE CAPITAL TRADING FUND, L.P. | 11/16/2011 | 10,987,500 | 0 |
| SC 13D/A | NOVARTIS AG | 12/15/2011 | 33,235,781 | 0 |
| SC 13G/A | PRICE T ROWE ASSOCIATES INC /MD/ | 02/10/2012 | 8,336,002 | 7,675,092 |
| SC 13G | BAUPOST GROUP LLC/MA | 02/10/2012 | 5,665,000 | 2,500,000 |
*Shares are split adjusted
